Zivile Bekassy
1 – 23 of 23
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Ophthalmic manifestations in children with tuberous sclerosis complex
(
- Contribution to journal › Article
- 2023
-
Mark
Is kidney biopsy necessary in children with idiopathic nephrotic syndrome?
(
- Contribution to journal › Article
-
Mark
Childhood tuberous sclerosis complex in southern Sweden: A paradigm shift in diagnosis and treatment.
(
- Contribution to journal › Article
- 2022
-
Mark
A role for complement blockade in kidney transplantation
(
- Contribution to journal › Article
-
Mark
Immunologic Control of Disseminated Aichi Virus Infection in X-Linked Agammaglobulinemia by Transplantation of TcRαβ-Depleted Haploidentical Hematopoietic Cells
(
- Contribution to journal › Letter
-
Mark
Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Aliskiren inhibits renin-mediated complement activation
(
- Contribution to journal › Article
-
Mark
Upptäckt av reninsubstrat kan leda till ny behandling för njursjukdom
(
- Contribution to journal › Debate/Note/Editorial
- 2016
-
Mark
Peritoneal dialysis impairs nitric oxide homeostasis and may predispose infants with low systolic blood pressure to cerebral ischemia
(
- Contribution to journal › Article
- 2015
-
Mark
A Novel Mechanism of Bacterial Toxin Transfer within Host Blood Cell-Derived Microvesicles.
(
- Contribution to journal › Article
-
Mark
NT-rådets ställningstagande till eculizumab är oacceptabelt
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Slutreplik, Diana Karpman och medförfattare : - NT-rådet bör omedelbart återkalla sitt beslut om eculizumab
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions.
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2014
-
Mark
Eculizumab treatment for rescue of renal function in IgA nephropathy.
(
- Contribution to journal › Article
- 2013
-
Mark
Studies of EHEC and the complement system in renal diseases
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.
(
- Contribution to journal › Article
- 2011
-
Mark
Intestinal damage in enterohemorrhagic Escherichia coli infection.
(
- Contribution to journal › Article
- 2010
-
Mark
Intestinal Damage in Enterohemorrhagic Escherichia coli (EHEC) Infection
2010) 15th Congress of the International Pediatric Nephrology Association In Pediatric Nephrology 25(9). p.1834-1834(
- Contribution to journal › Published meeting abstract
-
Mark
Biologically active ADAMTS13 is expressed in renal tubular epithelial cells.
(
- Contribution to journal › Article
- 2009
-
Mark
Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
Successful thrombolysis of neonatal bilateral renal vein thrombosis originating in the IVC.
(
- Contribution to journal › Article
- 2008
-
Mark
Successful treatment of bilateral renal venous thrombosis in a neonate
(
- Contribution to journal › Published meeting abstract
- 2002
-
Mark
Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections
(
- Contribution to journal › Article